Printer Friendly
The Free Library
4,488,943 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bruker Daltonics.


Bruker Daltonics was selected by Steyr-Daimler-Puch to provide its Raid-XP man-portable chemical agent and radiation detector for the Pandur wheeled armoured vehicles slated for delivery to the Czech Army. The primary mission of the Raid-XP is to protect vehicle crews from Gamma radiation and chemical agents, but can be removed for man-portable missions. The $ 40 million contract award will see the systems delivered over a multi-year period.

COPYRIGHT 2007 Armada International
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Business
Publication:Armada International
Date:Apr 1, 2007
Words:67
Previous Article:General Dynamics C4 Systems.(Business)
Next Article:Eads Defence & Security Systems.(Business)



Related Articles
Bruker BioSciences Announces Post-Merger Restructuring; Company to Consolidate Certain Production Sites While Strengthening Sales and Customer...
Clive Seymour Joins Bruker Daltonics as Vice President for Asia-Pacific.
Bruker Daltonics Appoints Dr. Michael Schubert as Vice President for Research and Development.
Bruker BioSciences Reports Second Quarter 2004 Results.
Bruker BioSciences Reports Third Quarter 2004 Financial Results.
Bruker BioSciences Reports Revenue of $85.8 Million, Operating Income of $3.6 Million and Net Income of $0.8 Million for the Fourth Quarter 2004.
Bruker BioSciences Reports Revenue Growth of 10% to $75 Million, Operating Income of $2.5 Million and Net Income of $0.4 Million for the First...
Bruker BioSciences Reports 11.3% Revenue Growth and Improved Operating Income, Net Income and Operating Cash Flow for the Second Quarter 2005.
Bruker BioSciences Reports 6.4% Revenue Growth and Improved Operating Income, Net Income and Operating Cash Flow for the Third Quarter 2005.(Company...
Bruker BioSciences Reports Significantly Improved Earnings and Cash Flows on Record Revenue of $297.6 Million For Full Year 2005.

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles